Richard Kim, Avadel, on the Future of Narcolepsy Care
Richard Kim, Chief Commercial Officer of Avadel, spoke about the “exciting” future of narcolepsy care, helped in part by the innovations developed by Avadel.
Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease
2025 Hume Award Winner Is Dedicated to Children’s Care
Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors